MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Pacific Biosciences of California Company Profile (NASDAQ:PACB)

Consensus Ratings for Pacific Biosciences of California (NASDAQ:PACB) (?)
Ratings Breakdown: 2 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $12.21 (50.24% upside)

Analysts' Ratings History for Pacific Biosciences of California (NASDAQ:PACB)
Show:
DateFirmActionRatingPrice TargetActions
4/15/2016MKM PartnersInitiated CoverageNeutral$16.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/14/2016First AnalysisInitiated CoverageOverweight$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2016StephensReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016JPMorgan Chase & Co.Boost Price Target$10.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016Piper JaffrayDowngradeOverweight -> Neutral$9.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Cantor FitzgeraldReiterated RatingBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2015William BlairReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/27/2015Maxim GroupReiterated RatingBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/26/2014 forward)
Earnings History for Pacific Biosciences of California (NASDAQ:PACB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016        
4/21/2016Q1($0.25)($0.23)$18.02 million$19.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2016Q4($0.02)($0.02)$36.96 million$36.28 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2015Q3($0.27)$0.02$15.84 million$13.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215($0.14)($0.16)$26.36 million$24.94 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q115($0.27)($0.27)$13.70 million$17.65 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2015Q414($0.26)($0.26)$14.90 million$16.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2014Q214($0.16)($0.13)$17.20 million$20.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2014Q114($0.15)($0.27)$11.39 million$11.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014($0.28)($0.28)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2014Q413($0.27)($0.26)$9.13 million$9.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2013Q313($0.30)($0.31)$7.08 million$7.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2013Q2 2013($0.35)($0.33)$6.09 million$6.04 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2013Q1 2013($0.37)($0.37)$4.28 million$5.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/5/2013Q4 2012($0.37)($0.39)$4.38 million$5.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2012($0.45)($0.41)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/26/2012($0.46)($0.40)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2012($0.47)($0.50)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/7/2012($0.50)($0.42)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2011($0.63)($0.42)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/27/2011($0.67)($0.66)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/15/2011($0.91)($0.97)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Pacific Biosciences of California (NASDAQ:PACB)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.26)($0.26)($0.26)
Q2 20161($0.23)($0.23)($0.23)
Q3 20161($0.17)($0.17)($0.17)
Q4 20161($0.19)($0.19)($0.19)
Q1 20171($0.19)($0.19)($0.19)
(Data provided by Zacks Investment Research)
Dividend History for Pacific Biosciences of California (NASDAQ:PACB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Pacific Biosciences of California (NASDAQ:PACB)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
4/25/2016James Michael PhillipsSVPSell20,000$10.29$205,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Brian B DowVPBuy2,503$4.91$12,289.73View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Kevin P CorcoranSVPBuy2,816$4.91$13,826.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2014William W EricsonDirectorBuy39,299$5.14$201,996.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2014William W EricsonDirectorBuy135,155$5.09$687,938.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2014William W EricsonDirectorBuy77,822$5.00$389,110.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014William W EricsonDirectorBuy29,435$4.93$145,114.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014William W EricsonDirectorBuy123,423$4.89$603,538.47View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2013Michael HunkapillerCEOBuy100,000$4.13$413,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/21/2013Michael HunkapillerCEOBuy200,000$3.61$722,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2012Michael HunkapillerCEOBuy154,100$1.75$269,675.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/29/2012Michael HunkapillerCEOBuy242,200$1.68$406,896.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2012Michael HunkapillerCEOBuy186,400$1.44$268,416.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2012Michael HunkapillerCEOBuy155,000$1.27$196,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/16/2012Michael HunkapillerCEOBuy262,300$1.16$304,268.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2012Michael HunkapillerCEOBuy400,000$1.75$700,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Pacific Biosciences of California (NASDAQ:PACB)
DateHeadline
06/24/16 08:20 AMLast Analysts Rating Review: Galena Biopharma, Inc. (NASDAQ:GALE) , Pacific Biosciences of California, Inc ... - Street Updates
06/24/16 08:20 AMHC Stocks Reports Analysis: Pacific Biosciences of California (NASDAQ:PACB), Envision Healthcare Holdings Inc ... - share market updates (press release)
06/24/16 07:50 AMCold Spring Harbor Laboratory Scientists Produce High-Quality Maize Transcriptome with PacBio SMRT Sequencing - [at noodls] - Friday, June 24, 2016 MENLO PARK, Calif., June 24, 2016 (GLOBE NEWSWIRE) - Improvements in maize breeding are required to feed a growing population and will depend on a more complete understanding of global ...
06/23/16 06:17 PMPacific Biosciences Of California, Inc. (NASDAQ:PACB) Current Analyst Ratings - Fiscal Standard
06/23/16 08:23 AMPacific Biosciences of California (NASDAQ:PACB) Analyst Rating Consensus - TheFounders Daily
06/17/16 11:15 AMPacific Biosciences of California, Inc. – Value Analysis (NASDAQ:PACB) : June 17, 2016 -
06/16/16 05:55 PMEarnings Analysis to see: ArcelorMittal (NYSE:MT), Pacific Biosciences of California, Inc. (NASDAQ:PACB) - Beacon Chronicle
06/16/16 09:56 AMAnalyst Recommended Stock: Pacific Biosciences of California, Inc. (NASDAQ:PACB) - News Oracle
06/16/16 09:56 AMInvestors Focused Movers: Pacific Biosciences of California, Inc. (NASDAQ:PACB) , Connecture, Inc. (NASDAQ:CNXR) - Street Updates
06/15/16 07:32 AMPacific Biosciences of California, Inc. breached its 50 day moving average in a Bearish Manner : PACB-US : June 15, 2016 -
06/11/16 05:53 PMPrice Target Update: Pacific Biosciences of California, Inc. (NASDAQ:PACB) - News Oracle
06/11/16 08:34 AMHC Stocks to Path: Pacific Biosciences of California (NASDAQ:PACB), Agios Pharmaceuticals Inc (NASDAQ:AGIO) - share market updates (press release)
06/10/16 08:43 AMComprehensive Report on: General Growth Properties, Inc (NYSE:GGP), Pacific Biosciences of California, Inc ... - Beacon Chronicle
06/09/16 06:05 PMStrong On High Volume: Pacific Biosciences Of California (PACB) - TheStreet.com
06/09/16 08:40 AMHC Stocks Analysis: Immunomedics, Inc. (NASDAQ:IMMU), Pacific Biosciences of California (NASDAQ:PACB) - share market updates (press release)
06/09/16 08:40 AMStocks Showing Movement: Restoration Hardware Holdings, Inc. (NYSE:RH), Pacific Biosciences of California, Inc ... - Beacon Chronicle
06/08/16 06:06 PMPACIFIC BIOSCIENCES OF CALIFORNIA INC. (NASDAQ:PACB) Financial Condition Compared to S&P 500 - CML News
06/08/16 08:42 AMPacific Biosciences of California Inc. (PACB) is Trading Lower on Unusual Volume for June 06 - Equities.com
06/07/16 05:54 PMHot Stock under Consideration: Pacific Biosciences of California, Inc. (NASDAQ:PACB) - News Oracle
06/06/16 05:39 PMTrending Stock Analysis: Pacific Biosciences of California, Inc. (NASDAQ:PACB) - News Oracle
06/06/16 05:39 PMStocks with Buy Rating: Pacific Biosciences of California, Inc. (NASDAQ:PACB), PulteGroup, Inc. (NYSE:PHM) - Beacon Chronicle
06/06/16 09:23 AMObserving Healthcare Stocks Update: Abbott Laboratories (NYSE:ABT) , Pacific Biosciences of California, Inc ... - Is stories
06/06/16 09:23 AMHC Stocks Movements to Focus: Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Pacific Biosciences of California ... - share market updates (press release)
06/03/16 06:14 PMAnalysts Observing Stocks: Endo International plc (NASDAQ:ENDP) , Pacific Biosciences of California, Inc. (NASDAQ ... - Street Updates
06/03/16 06:14 PMPacific Biosciences of California, Inc. (NASDAQ:PACB) Stock Update & Estimates - Stock Tick Tock
06/03/16 06:14 PMStock's Earnings Activity: Pacific Biosciences of California, Inc. (NASDAQ:PACB), Halcon Resources Corporation ... - Beacon Chronicle
06/02/16 06:06 PMStocks Update: Gilead Sciences, Inc. (NASDAQ:GILD) , Pacific Biosciences of California, Inc. (NASDAQ:PACB) - Is stories - Stocks Update: Gilead Sciences, Inc. (NASDAQ:GILD) , Pacific Biosciences of California, Inc. (NASDAQ:PACB)Is storiesIn most recently trading session on 6/1/2016, Pacific Biosciences of California, Inc. (NASDAQ:PACB) climbed +0.93% while traded on 2.16 million shares versus it's an average volume of 1.48 million shares. The company recorded the last trade with the ...and more »
06/02/16 06:06 PMEarnings Trends of the Stock: Pacific Biosciences of California, Inc. (NASDAQ:PACB), Post Holdings, Inc. (NYSE:POST) - Beacon Chronicle - Beacon ChronicleEarnings Trends of the Stock: Pacific Biosciences of California, Inc. (NASDAQ:PACB), Post Holdings, Inc. (NYSE:POST)Beacon Chronicle... the Average Revenue Estimate of the current Fiscal quarter is $20.17 Million and according to them, the Low Revenue estimate is $19.4 Million and High Revenue estimate is $21 Million. Pacific Biosciences of California, Inc. (NASDAQ:PACB) currently ...and more »
06/01/16 06:12 PMAlibaba Group (NYSE:BABA) Plunged-4.00% Premarket: Pacific Biosciences of California (NASDAQ:PACB), EnerSys ... - KC Register - Alibaba Group (NYSE:BABA) Plunged-4.00% Premarket: Pacific Biosciences of California (NASDAQ:PACB), EnerSys ...KC RegisterVetr upgraded shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB) from a hold rating to a buy rating in a research report sent to investors. The firm currently has $10.42 target price on the stock. A number of other research firms also ...J C Penney (NYSE:JCP) to refinance $2.25 billion real estate loan: ArcelorMittal (NYSE:MT), McDonald's (NYSE:MCD ...Benchmark Monitorall 17 news articles »
06/01/16 08:37 AMPacific Biosciences of California Inc. (PACB) Jumps 5.24% on May 31 - Equities.com - Pacific Biosciences of California Inc. (PACB) Jumps 5.24% on May 31Equities.comPacific Biosciences of California Inc. (PACB) was among the biggest gainers on the Russell 2000 for Tuesday May 31 as the stock popped 5.24% to $9.64, representing a gain of $0.48 per share. Some 3.34 million shares traded hands on 16,493 trades, ...and more »
06/01/16 08:37 AMHC Stocks Midpoint: Pacific Biosciences of California (NASDAQ:PACB), Array Biopharma Inc (NASDAQ:ARRY) - share market updates (press release) - share market updates (press release)HC Stocks Midpoint: Pacific Biosciences of California (NASDAQ:PACB), Array Biopharma Inc (NASDAQ:ARRY)share market updates (press release)Shares of Pacific Biosciences of California (NASDAQ:PACB) ended Tuesday session in green amid volatile trading. The shares closed up +0.48 points or 5.24% at $9.64 with 3.39 million shares getting traded. Post opening the session at $9.32, the shares ...Broker Changes For Pacific Biosciences Of California, Inc. (NASDAQ:PACB)Risers & FallersAttention Grabbing Stocks of Healthcare: ChemoCentryx Inc (NASDAQ:CCXI), Pacific Biosciences of California ...The Point Reviewall 4 news articles »
05/31/16 05:58 PMEarnings Review: Pacific Biosciences (PACB), DENTSPLY SIRONA (XRAY) - Beacon Chronicle - Beacon ChronicleEarnings Review: Pacific Biosciences (PACB), DENTSPLY SIRONA (XRAY)Beacon Chronicle... the Low Revenue estimate is $ 19.40 Million and High Revenue estimate is $ 21.00 Million. Pacific Biosciences of California (NASDAQ:PACB) currently has High Price Target of $ 18.00. The Low and Mean Price Targets are $ 11.00 and $ 12.80 ...and more »
05/31/16 05:58 PMPacific Biosciences of California (NASDAQ:PACB) Receives Consensus Recommendation of “Buy” from Analysts - Let Me Know About This - iStreetWirePacific Biosciences of California (NASDAQ:PACB) Receives Consensus Recommendation of “Buy” from AnalystsLet Me Know About ThisPacific Biosciences of California logo Pacific Biosciences of California (NASDAQ:PACB) has been given a consensus recommendation of “Buy” by the ten research firms that are covering the firm. Two research analysts have rated the stock with a hold ...Ghost Tree Capital Lowers stake in Pacific Biosciences of California (PACB)Market DigestPacific Biosciences of California, Inc. (NASDAQ:PACB) 1-Year High At $14.00RealistInvestor.comPacific Biosciences Of California, Inc. (NASDAQ:PACB) Broker Price Targets For The Coming WeekShare Trading NewsiStreetWire -HNNall 6 news articles »
05/30/16 11:03 AMHC Stock's Move to Focus: Pacific Biosciences of California (NASDAQ:PACB), DENTSPLY SIRONA Inc (NASDAQ:XRAY) - share market updates (press release) - share market updates (press release)HC Stock's Move to Focus: Pacific Biosciences of California (NASDAQ:PACB), DENTSPLY SIRONA Inc (NASDAQ:XRAY)share market updates (press release)Shares of Pacific Biosciences of California (NASDAQ:PACB) ended Friday session in green amid volatile trading. The shares closed up +0.30 points or 3.39% at $9.16 with 1.33 million shares getting traded. Post opening the session at $8.92, the shares ...and more »
05/26/16 05:39 AMWere Analysts Bearish Pacific Biosciences of California (NASDAQ:PACB) This Week? - Wall Street Hints and News - Is storiesWere Analysts Bearish Pacific Biosciences of California (NASDAQ:PACB) This Week?Wall Street Hints and NewsOut of 5 analysts covering Pacific Biosciences of California (NASDAQ:PACB), 4 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 67% are positive. Pacific Biosciences of California has been the topic of 9 analyst reports since August 27, 2015 ...Broker Outlook For Pacific Biosciences Of California, Inc. (NASDAQ:PACB)Share Trading NewsObserving Healthcare Stocks Update: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) , Pacific Biosciences of California ...Is storiesBiotech Companies To Look Out For: Celldex Therapeutics, Inc. (CLDX), Pacific Biosciences of California, Inc. (PACB)Zergwatchall 5 news articles »
05/25/16 01:27 PMObserving Healthcare Stocks Update: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) , Pacific Biosciences of California ... - Is stories - Is storiesObserving Healthcare Stocks Update: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) , Pacific Biosciences of California ...Is storiesShares of Pacific Biosciences of California, Inc. (NASDAQ:PACB) declined -2.38% and ended at $9.43 smaller than previous closing price of $9.66. The total 1.1 million shares were bought and sold throughout the most recent trading session less than ...Biotech Companies To Look Out For: Celldex Therapeutics, Inc. (CLDX), Pacific Biosciences of California, Inc. (PACB)Zergwatchall 5 news articles »
05/25/16 01:27 PMHC Stocks Movements to Focus: Pacific Biosciences of California (NASDAQ:PACB), Omeros Corporation (NASDAQ ... - share market updates (press release) - HC Stocks Movements to Focus: Pacific Biosciences of California (NASDAQ:PACB), Omeros Corporation (NASDAQ ...share market updates (press release)Shares of Pacific Biosciences of California (NASDAQ:PACB) ended Friday session in green amid volatile trading. The shares closed down -0.08 points or -0.82% at $9.64 with 1.95 million shares getting traded. Post opening the session at $9.30, the shares ...
05/25/16 01:27 PMNotable Analysts Ratings: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) , Pacific Biosciences of California, Inc ... - Street Updates - Notable Analysts Ratings: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) , Pacific Biosciences of California, Inc ...Street UpdatesPacific Biosciences of California, Inc. (NASDAQ:PACB) after beginning at $9.65, closed at $9.66 by building up +0.21% in recent trading session. Most recent session's volume of 2.88 million shares greater than its average volume of 1.42 million shares.and more »
05/24/16 01:54 PMNoteworthy Monday Option Activity: GOOG, PACB, WSM - Today's Most Active Call & Put Options of the S&P 500 » Pacific Biosciences of California Inc (NASDAQ:PACB) saw options trading volume of 8,614 contracts, representing approximately 861,400 underlying shares or approximately 59.9% of PACB's average daily ...
05/24/16 01:54 PMPacific Biosciences of California, Inc. (NASDAQ:PACB) at $9.64: How much higher it can go - Pacific Biosciences of California, Inc. (PACB) up 9.42 per cent in the past week, is under coverage of 0 analysts who collectively recommend a buy rating on stock. 0 of the analysts have a buy or better rating; the 0 sells versus 0 underperforms.
05/21/16 01:15 PMAlpha One Assigns Impact Score Of 80 To Pacific Biosciences of California, Inc. (NASDAQ:PACB) - RealistInvestor.com - Alpha One Assigns Impact Score Of 80 To Pacific Biosciences of California, Inc. (NASDAQ:PACB)RealistInvestor.comAlpha One analyzed the various web articles published on Pacific Biosciences of California, Inc. (NASDAQ:PACB), and thereafter it gave company a daily sentiment score of 0.498. The entity designs algorithm based assessment to known stock sentiment on ...and more »
05/20/16 01:38 PMTrending Stock Update: Pacific Biosciences of California (NASDAQ:PACB) - News Oracle - News OracleTrending Stock Update: Pacific Biosciences of California (NASDAQ:PACB)News OracleBy looking at Pacific Biosciences of California (NASDAQ:PACB) YTD (year to date) performance, the stock shows Negative value of -25.97%. If the YTD value is Negative, it means that the stock is trading poorly. If the YTD value is Positive, this means ...Pacific Biosciences Of California, Inc. (NASDAQ:PACB) Updated Broker Price TargetsShare Trading NewsMorning Watch List: Pacific Biosciences of California (NASDAQ:PACB), Facebook Inc (NASDAQ:FB), Weyerhaeuser ...KC RegisterBiotech Stocks Worth Chasing: MannKind Corp. (MNKD), Pacific Biosciences of California, Inc. (PACB)Zergwatchall 4 news articles »
05/20/16 01:38 PMPacific Biosciences of California, Inc. (NASDAQ:PACB) One-Year Price Projection At $12 - Stocks Daily - Pacific Biosciences of California, Inc. (NASDAQ:PACB) One-Year Price Projection At $12Stocks DailySell-side analysts are certain on the prospect of Pacific Biosciences of California, Inc. (NASDAQ:PACB) stock. As of 2016-05-19, the stock ABR stands at 1.5. This type of rating states that whenever a stock has a score of 5, investors should avoid ...and more »
05/19/16 03:18 PMPACIFIC BIOSCIENCES OF CALIFORNIA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
05/18/16 09:45 PMETF’s with exposure to Pacific Biosciences of California, Inc. : May 19, 2016 -
05/18/16 01:57 PMPacific Biosciences Of California (PACB) Strong On High Relative Volume Today - TheStreet.com - Pacific Biosciences Of California (PACB) Strong On High Relative Volume TodayTheStreet.comTrade-Ideas LLC identified Pacific Biosciences of California ( PACB) as a strong on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Pacific Biosciences of California as such a stock due to the ...and more »
05/17/16 07:07 AMPacific Biosciences of California, Inc. breached its 50 day moving average in a Bullish Manner : PACB-US : May 17, 2016 -
05/13/16 07:55 AMOverview of Price Moves: Pacific Biosciences of California, Inc. (NASDAQ:PACB) , Regeneron Pharmaceuticals, Inc ... - Street Updates - Overview of Price Moves: Pacific Biosciences of California, Inc. (NASDAQ:PACB) , Regeneron Pharmaceuticals, Inc ...Street UpdatesOn 5/11/2016, Pacific Biosciences of California, Inc. (NASDAQ:PACB) ended trading session higher at $9.08 with +2.60%. The company traded a volume of 1.39 million shares as comparison to average volume of 1.38 million shares. During the 52 –week ...and more »
05/12/16 12:04 PMPACIFIC BIOSCIENCES OF CALIFORNIA, INC. Financials -
05/11/16 07:12 AMConsensus Rating Review for Pacific Biosciences of California, Inc. (NASDAQ:PACB) - B.O.D.Y Confidential - Consensus Rating Review for Pacific Biosciences of California, Inc. (NASDAQ:PACB)B.O.D.Y ConfidentialEquity research analysts currently have a consensus rating of 1.5 on shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB). Sell-side analysts will typically rate a company's stock based on extensive research. These ratings usually translate ...and more »
About Pacific Biosciences of California

Pacific Biosciences of California logoPacific Biosciences of California Inc. designs, develops and manufactures the PacBio RS II Sequencing System to help scientists resolve genetically complex problems. Based on the Company's Single Molecule, Real-Time (SMRT) technology, its products enable de novo genome assembly to finish genomes in order to more fully identify, annotate and decipher genomic structures; full-length transcript analysis to improve annotations in reference genomes, characterize alternatively spliced isoforms and find genes; targeted sequencing to more comprehensively characterize genetic variations; and DNA (deoxyribonucleic acid) base modification identification to help characterize epigenetic regulation and DNA damage. SMRT enables single molecule, real-time detection of biological processes. Based on its SMRT technology, the Company introduced the PacBio RS II System to address many of the limitations.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: PACB
  • CUSIP: 69404D10
Key Metrics:
  • Previous Close: $8.60
  • 50 Day Moving Average: $9.18
  • 200 Day Moving Average: $9.79
  • P/E Ratio: N/A
  • P/E Growth: -0.32
  • Market Cap: $708.68M
  • Current Quarter EPS Consensus Estimate: $-0.85 EPS
Additional Links:
Pacific Biosciences of California (NASDAQ:PACB) Chart for Sunday, June, 26, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha